» Articles » PMID: 27015536

Expression and Association of the Yersinia Pestis Translocon Proteins, YopB and YopD, Are Facilitated by Nanolipoprotein Particles

Abstract

Yersinia pestis enters host cells and evades host defenses, in part, through interactions between Yersinia pestis proteins and host membranes. One such interaction is through the type III secretion system, which uses a highly conserved and ordered complex for Yersinia pestis outer membrane effector protein translocation called the injectisome. The portion of the injectisome that interacts directly with host cell membranes is referred to as the translocon. The translocon is believed to form a pore allowing effector molecules to enter host cells. To facilitate mechanistic studies of the translocon, we have developed a cell-free approach for expressing translocon pore proteins as a complex supported in a bilayer membrane mimetic nano-scaffold known as a nanolipoprotein particle (NLP) Initial results show cell-free expression of Yersinia pestis outer membrane proteins YopB and YopD was enhanced in the presence of liposomes. However, these complexes tended to aggregate and precipitate. With the addition of co-expressed (NLP) forming components, the YopB and/or YopD complex was rendered soluble, increasing the yield of protein for biophysical studies. Biophysical methods such as Atomic Force Microscopy and Fluorescence Correlation Spectroscopy were used to confirm that the soluble YopB/D complex was associated with NLPs. An interaction between the YopB/D complex and NLP was validated by immunoprecipitation. The YopB/D translocon complex embedded in a NLP provides a platform for protein interaction studies between pathogen and host proteins. These studies will help elucidate the poorly understood mechanism which enables this pathogen to inject effector proteins into host cells, thus evading host defenses.

Citing Articles

Macrophage innate immune responses delineate between defective translocon assemblies produced by YopD mutants.

Farag S, Francis M, Gurung J, Nyunt Wai S, Stenlund H, Francis M Virulence. 2023; 14(1):2249790.

PMID: 37621095 PMC: 10461508. DOI: 10.1080/21505594.2023.2249790.


Type III Secretion in .

Rucks E Microbiol Mol Biol Rev. 2023; 87(3):e0003423.

PMID: 37358451 PMC: 10521360. DOI: 10.1128/mmbr.00034-23.


Biophysical Characterization of Membrane Proteins Embedded in Nanodiscs Using Fluorescence Correlation Spectroscopy.

Laurence M, Carpenter T, Laurence T, Coleman M, Shelby M, Liu C Membranes (Basel). 2022; 12(4).

PMID: 35448362 PMC: 9028781. DOI: 10.3390/membranes12040392.


Cell-free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development.

Gilmore S, He W, Evans A, Tifrea D, Pal S, Segelke B J Vis Exp. 2022; (181).

PMID: 35377358 PMC: 9236854. DOI: 10.3791/63028.


Delivering the pain: an overview of the type III secretion system with special consideration for aquatic pathogens.

Rahmatelahi H, El-Matbouli M, Menanteau-Ledouble S Vet Res. 2021; 52(1):146.

PMID: 34924019 PMC: 8684695. DOI: 10.1186/s13567-021-01015-8.


References
1.
Andrews G, Strachan S, Benner G, Sample A, Anderson Jr G, Adamovicz J . Protective efficacy of recombinant Yersinia outer proteins against bubonic plague caused by encapsulated and nonencapsulated Yersinia pestis. Infect Immun. 1999; 67(3):1533-7. PMC: 96493. DOI: 10.1128/IAI.67.3.1533-1537.1999. View

2.
Francis M, Wolf-Watz H . YopD of Yersinia pseudotuberculosis is translocated into the cytosol of HeLa epithelial cells: evidence of a structural domain necessary for translocation. Mol Microbiol. 1998; 29(3):799-813. DOI: 10.1046/j.1365-2958.1998.00973.x. View

3.
Ryndak M, Chung H, London E, Bliska J . Role of predicted transmembrane domains for type III translocation, pore formation, and signaling by the Yersinia pseudotuberculosis YopB protein. Infect Immun. 2005; 73(4):2433-43. PMC: 1087397. DOI: 10.1128/IAI.73.4.2433-2443.2005. View

4.
Goure J, Broz P, Attree O, Cornelis G, Attree I . Protective anti-V antibodies inhibit Pseudomonas and Yersinia translocon assembly within host membranes. J Infect Dis. 2005; 192(2):218-25. DOI: 10.1086/430932. View

5.
Mueller C, Broz P, Muller S, Ringler P, Erne-Brand F, Sorg I . The V-antigen of Yersinia forms a distinct structure at the tip of injectisome needles. Science. 2005; 310(5748):674-6. DOI: 10.1126/science.1118476. View